Other Clinical Trial - Morphine for Dyspnea in Pulmonary Fibrosis

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05119972` - Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF）	Phase 1/Phase 2
Completed	`NCT01718990` - Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
Completed	`NCT00162760` - Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide	Phase 2
Terminated	`NCT04589260` - TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis	Phase 1
Completed	`NCT04069143` - A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327	Phase 1
Completed	`NCT03050255` - Short-term Effects of Supplemental Oxygen in Patients With IPF	N/A
Terminated	`NCT02013700` - Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER)	Phase 1
Active, not recruiting	`NCT04598919` - Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis	Phase 1/Phase 2
Completed	`NCT03981094` - A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants	Phase 1
Completed	`NCT02758808` - Pulmonary Fibrosis Foundation Patient Registry
Not yet recruiting	`NCT05387785` - Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis	Phase 1
Active, not recruiting	`NCT05938920` - Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)	Phase 2
Completed	`NCT02538536` - A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)	Phase 2
Completed	`NCT01371305` - STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)	Phase 2
Withdrawn	`NCT03720483` - Inhaled NAC in Treatment of IPF	Phase 1/Phase 2
Recruiting	`NCT03478553` - The Genetics of Pulmonary Fibrosis
Recruiting	`NCT05975983` - Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis	Phase 2
Completed	`NCT03650075` - To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers	Phase 1
Completed	`NCT03832946` - A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)	Phase 2
Completed	`NCT02874989` - Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial	Phase 1

NCT number	NCT04497831
Study type	Interventional
Source	Medical University of Gdansk
Contact
Status	Not yet recruiting
Phase	Phase 3
Start date	September 21, 2020
Completion date	September 21, 2022

Morphine for Dyspnea in Pulmonary Fibrosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms